UAB receives $4 million from Novo Nordisk to expand Live HealthSmart Alabama health initiative
The University of Alabama at Birmingham (UAB) received a $4 million investment from pharmaceutical company Novo Nordisk to expand its Live HealthSmart Alabama initiative. The program, founded in 2019, provides free mobile wellness screenings, access to fresh produce, and health education across Alabama. The funding, distributed over three years through Novo Nordisk's social impact program The Interrupt, will expand services to communities including Clanton, Oneonta, and Montgomery.
Key quotes
The University of Alabama at Birmingham announced Tuesday that pharmaceutical company Novo Nordisk is investing $4 million to support the university's Live HealthSmart Alabama program.
Live HealthSmart Alabama, founded by UAB in 2019, operates programs that offer free mobile pop-up wellness screenings, resources to help Alabamians access fresh fruits and vegetables, and health and nutrition education initiatives.
The funding, contributed through Novo Nordisk's social impact program, The Interrupt, will be disbursed to Live HealthSmart Alabama over the next three years.
From the article
The investment will expand mobile screenings, nutrition resources and community-led health programs to communities such as Clanton, Oneonta and Montgomery.
Continue reading on alreporter.comYou might also wanna read
Novo Nordisk-Aktie: Singapur-News? First-Mover-Vorteil bleibt wichtiger!
aktiencheck.de
UK Health App “Cera” Raises $150M to Enhance AI-Driven Home Healthcare
ASO World·1y ago
Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical
Fierce Biotech·2d ago
Novo Nordisk moves to launch Wegovy tablet in China
scandasia.com·21d ago
Alchemab Therapeutics extends Series A with £25m investment
UKTN·6h ago
Novo Nordisk: Schritt für Schritt
aktiencheck.de
Comments
Sign in to join the conversation.
No comments yet. Be the first.